13F Holdings
中文EN

BEAT HeartBeam, Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1779372 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY12.5%
TTM EPS YoY40.9%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-521.7%
ROA-335.9%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets17.3%
Debt / equity0.00x
Current ratio4.64x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.69x
Accruals ratio-104.3%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue—————
R&D expense$13.45M$11.05M$6.80M$5.68M$255,000
SG&A expense$7.69M$8.84M$8.52M$7.35M$2.03M
Operating income-$21.14M-$19.89M-$15.31M-$13.03M-$2.29M
Interest expense————$2.17M
Pretax income-$21.02M-$19.45M-$14.64M-$12.96M-$4.43M
Income tax$0$0$0$0$0
Net income-$21.02M-$19.45M-$14.64M-$12.96M-$4.43M
EBITDA-$21.10M-$19.88M-$15.31M——
EPS (basic)-0.62-0.73-0.72-1.59-1.03
EPS (diluted)-0.62-0.73-0.72-1.59-1.03
Weighted avg. shares (diluted)33.71M26.65M20.33M8.17M4.28M
Balance sheet
Cash & equivalents$4.38M$2.43M$16.24M$3.59M$13.19M
Inventory$103,000$0———
Current assets$4.68M$2.77M$16.82M$4.04M—
PP&E, net$1.10M$450,000$256,000$0—
Total assets$5.84M$3.28M$17.13M$4.04M$14.00M
Current liabilities$3.24M$1.62M$1.19M——
Total liabilities$3.24M$1.62M$1.19M$1.67M$588,000
Shareholders' equity$2.60M$1.65M$15.94M$2.37M$13.41M
Shares outstanding40.12M26.96M26.33M8.01M7.81M
Cash flow statement
Operating cash flow-$13.99M-$14.47M-$12.09M-$9.95M-$3.23M
Capital expenditure$600,000$201,000$256,000$0—
Free cash flow-$14.59M-$14.67M-$12.35M-$9.95M—
Investing cash flow-$600,000-$201,000-$256,000$0—
Financing cash flow$16.59M$866,000$24.99M$350,000$16.40M
Depreciation & amortization$40,000$7,000$0——
Stock-based compensation$5.15M$4.30M$3.21M$1.12M$192,000

Free plan shows the latest 5 periods; Pro shows all 6 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.